Skip Navigation

Microplastics May Worsen Fatty Liver Disease, New Study Suggests

NEWS
A graphic that reads "study reveals how microplastics disrupt liver health."
Image by Daniel Deering.

Microplastics May Worsen Fatty Liver Disease, New Study Suggests

Advanced Mapping Technology Reveals Hidden Effects of Microplastics


By

April Wilkerson
april-j-wilkerson@ou.edu

Date

June 17, 2026

OKLAHOMA CITY – Microplastics – minuscule pieces of plastic broken down from larger plastic waste – are a growing concern for human health, especially for the liver. A study from the University of Oklahoma, published today in Science Advances, demonstrates that a common type of microplastics is particularly harmful to the liver under high-fat dietary conditions.

The study, conducted in mice, found that blood markers of liver injury were more than twice as high in animals exposed to microplastics while consuming a high-fat diet compared with animals exposed to the same particles while consuming a standard diet. The study focused on the most common type of plastic, polyethylene, which is found in materials like plastic bags and milk jugs.

“Exposure to microplastics is inevitable. We inhale them, ingest them and they are on our skin,” said Tae Gyu Oh, Ph.D., who led the study and is an assistant professor of oncology science in the OU College of Medicine. “Numerous studies have shown the presence of microplastics in our bodies, but we wanted to investigate the effects of microplastics in the setting of a high-fat, high-cholesterol diet, which has also been shown to harm the liver. We expected to see a synergistic effect between the diet and microplastics, and we did.”

In the study, researchers administered microplastics in equal amounts to the mice over eight weeks. Some of the mice were fed a standard diet, and others were fed a diet designed to model metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease.

To better understand what was happening inside the liver, Oh and his team examined the liver tissue using a variety of technologies that increasingly “zoomed in” on the cells. Each technology showed liver damage, but the highest resolution was provided through spatial transcriptomics. The research team’s use of the technology in this context is believed to be a first.

Whereas traditional technology (such as bulk transcriptomics) showed a single, averaged reading of millions of cells, spatial transcriptomics pinpointed exactly where the damage occurred.

“This high-resolution view helped us identify specific ‘hot spots’ of liver damage at the single-cell level that would have been impossible to detect using traditional approaches,” Oh said.

The study also identified a gene regulator known as PPAR-alpha as playing a key role in the liver’s response to microplastic exposure. PPAR-alpha, a protein inside the cells that controls how the body breaks down and uses fat for energy, influences a gene called Anxa2, which plays a role in tissue repair.

“These findings suggest that microplastics may affect some of the liver’s natural defense and repair mechanisms,” Oh said. “Understanding this relationship may point us toward new ways to protect liver health.”

Although the research was conducted in mice and additional research is needed to determine whether the same effects occur in humans, the study establishes a framework for understanding how microplastics may contribute to liver disease.

“Microplastics are now part of our everyday environment, but we are still learning how they affect the body,” Oh said. “By gaining such a detailed look at the liver, we were able to see specific regions where microplastic exposure triggered inflammation and altered important biological pathways. These findings provide new clues about how environmental exposures may contribute to liver disease and point to areas for future investigation.”

About the project

The paper, “Spatial Transcriptome Mapping Identifies Ppara-Anxa2 Crosstalk in Microplastic-Induced Hepatotoxicity,” is at https://doi.org/10.1126/sciadv.aec8681. Co-corresponding author is Aditya D. Joshi, Ph.D., with Texas A&M University. First author is Woncheol Jung, Ph.D., with the Department of Oncology Science in the OU College of Medicine.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, the OU Health Campus is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. The OU Health Campus serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about the OU Health Campus, visit www.ouhsc.edu.


Recent News

Research
October 01, 2026

OU-led projects aims to recover critical minerals from existing oil and gas wells

The University of Oklahoma, partnering with the state of Oklahoma and academic and industry partners, has received funding from the U.S. National Science Foundation to build the nation’s first integrated platform for recovering critical minerals from existing oil and gas wells.


Impact
September 30, 2026

OU Extends Path to Higher Education for More Oklahoma Families Than Ever

More Oklahoma families than ever will have a clear and affordable path to a University of Oklahoma education with the launch of OU Onward, a new scholarship that will help cover tuition and average fees at OU for qualifying Oklahoma students whose families earn between $60,000 and $75,000 annually.


Research
September 29, 2026

Cell Paper Identifies Subclusters Driving Cancer-Induced Cachexia

Research published today in Cell identifies three small subclusters of cells driving pancreatic cancer-induced cachexia, a muscle-wasting and fat-loss condition that makes patients less tolerant of cancer treatment. The study, led by the University of Oklahoma, holds significant promise for the development of therapeutics to target these subclusters.